Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology

Autor: Mark Kidd, Irvin M. Modlin, Ignat Drozdov, Lisa Bodei
Jazyk: angličtina
Předmět:
ISG
immature secretory vesicles

Proliferation
Review
CgA
chromogranin A

Metastasis
Transcriptome
GEP-NEN
gastroenteropancreatic neuroendocrine neoplasms

CGH
comparative genomic hybridization

TGF
transforming growth factor

D cell
somatostatin

biology
PI3K
phosphoinositide-3 kinase

Gastroenterology
Chromogranin A
MSI
microsatellite instability

cAMP
adenosine 3′
5′-cyclic monophosphate

EC
enterochromaffin

Blood
TSC2
tuberous sclerosis complex 2 (tuberin)

VMAT
vesicular monoamine transporters

Protein kinase B signaling
MEN-1/MEN1
multiple endocrine neoplasia type 1

Ki-67
miR/miRNA
micro-RNA

Somatostatin
X/A-like cells
ghrelin

Gastroenteropancreatic Neuroendocrine Neoplasms
NEN
neuroendocrine neoplasms

mTOR
mammalian target of rapamycin

Computational biology
ERK
extracellular-signal-regulated kinase

PET
positron emission tomography

5-HT
serotonin
5-hydroxytryptamine

SD-208
2-(5-chloro-2-fluorophenyl)-4-[(4-pyridyl)amino]p-teridine

MTA
metastasis associated-1

PI3
phosphoinositide-3

PKC
protein kinase C

medicine
PTEN
lcsh:RC799-869
LOH
loss of heterozygosity

Grading (tumors)
SNV
single-nucleotide variant

PTEN
phosphatase and tensin homolog deleted on chromosome 10

Hepatology
IGF-I
insulin-like growth factor-I

TGN
trans-Golgi network

medicine.disease
Carcinoid
EGFR
epidermal growth factor receptor

GPCR
G-protein coupled receptor

NFκB
nuclear factor κB

SSA
somatostatin analog

ECL
enterochromaffin-like

Akt
protein kinase B

Cancer research
biology.protein
CREB
cAMP response element-binding protein

lcsh:Diseases of the digestive system. Gastroenterology
PKA
protein kinase A

BRAF
gene encoding serine/threonine-protein kinase B-Raf

TSC2
G cell
gastrin

SST
somatostatin

DAG
diacylglycerol

GABA
γ-aminobutyric acid

MAPK
mitogen-activated protein kinase

Comparative genomic hybridization
Zdroj: Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 1, Iss 2, Pp 131-153 (2015)
ISSN: 2352-345X
DOI: 10.1016/j.jcmgh.2014.12.008
Popis: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and outcome depends on cell type, secretory product, histopathologic grading, and organ of origin. A morphologic and molecular genomic review of these lesions highlights tumor characteristics that can be used clinically, such as somatostatin-receptor expression, and confirms features that set them outside the standard neoplasia paradigm. Their unique pathobiology is useful for developing diagnostics using somatostatin-receptor targeted imaging or uptake of radiolabeled amino acids specific to secretory products or metabolism. Therapy has evolved via targeting of protein kinase B signaling or somatostatin receptors with drugs or isotopes (peptide-receptor radiotherapy). With DNA sequencing, rarely identified activating mutations confirm that tumor suppressor genes are relevant. Genomic approaches focusing on cancer-associated genes and signaling pathways likely will remain uninformative. Their uniquely dissimilar molecular profiles mean individual tumors are unlikely to be easily or uniformly targeted by therapeutics currently linked to standard cancer genetic paradigms. The prevalence of menin mutations in pancreatic NEN and P27KIP1 mutations in small intestinal NEN represents initial steps to identifying a regulatory commonality in GEP-NEN. Transcriptional profiling and network-based analyses may define the cellular toolkit. Multianalyte diagnostic tools facilitate more accurate molecular pathologic delineations of NEN for assessing prognosis and identifying strategies for individualized patient treatment. GEP-NEN remain unique, poorly understood entities, and insight into their pathobiology and molecular mechanisms of growth and metastasis will help identify the diagnostic and therapeutic weaknesses of this neoplasia. Keywords: Gastroenteropancreatic Neuroendocrine Neoplasms, Blood, Carcinoid, Ki-67, Proliferation, Somatostatin, Transcriptome
Databáze: OpenAIRE